Publisher： Bentham Science Publishers
E-ISSN： 1875-533x|12|7|751-778
ISSN： 0929-8673
Source： Current Medicinal Chemistry, Vol.12, Iss.7, 2005-04, pp. : 751-778
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Magnetic resonance imaging (MRI) contrast agents are utilized adjunctively to enhance the contrast between normal and abnormal structures on MRI scans. Along with the rapid evolution of the field has come a new appreciation for the medicinal chemistry of this unique class of metallopharmaceuticals. The efficacy of MRI agents is a complex function of chemical, biophysical, and pharmacological properties, which must be married in a package of exquisite safety. This report illustrates the wide range of medicinal chemistry relevant to existing agents that are either approved or in clinical development, as well as concepts, which may result in exciting new pharmaceuticals in the future.
Related content
Access to resources
Recommend
Dynamic Contrast-Enhanced MRI in Oncology Drug Development
Current Clinical Pharmacology, Vol. 2, Iss. 2, 2007-05 ,pp. :
Chemistry of Tumour Targeted T1 Based MRI Contrast Agents
Current Topics in Medicinal Chemistry, Vol. 10, Iss. 12, 2010-08 ,pp. :